Schizophrenia Research Institute, Liverpool Street, Darlinghurst, NSW, Australia; Neuroscience Research Australia, Barker Street, Randwick, NSW, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
NPJ Schizophr. 2015 Mar 4;1:14004. doi: 10.1038/npjschz.2014.4. eCollection 2015.
Recently, we provided evidence showing reductions in GAD67 and Dlx mRNAs in the orbital frontal cortex (OFC) in schizophrenia. It is unknown whether these reductions relate mainly to somatostatin (SST) or parvalbumin (PV) mRNA expression changes, and/or whether these reductions are related to decreased SST mRNA+ interneuron density.
To determine whether inhibitory interneuron deficits in the OFC from people with schizophrenia are greatest for SST or PV mRNAs, and whether any such deficits relate to mRNAs encoding cell death signalling molecules.
Inhibitory interneuron mRNAs (SST; PV: in situ hybridization, quantitative PCR (qPCR)) and death signaling mRNAs [FAS receptor (FASR); TNFSF13: qPCR] were measured in control and schizophrenia subjects (38/38). SST mRNA+ interneuron-like cells were quantified in layer II in the gyrus rectus. Gray matter SST and PV mRNAs were correlated with interstitial white matter neuron (IWMN) density (GAD65/67; NeuN) and death signaling mRNAs.
SST mRNA was reduced in OFC layers I-VI in schizophrenia (both in situ and qPCR), with greatest deficit in layer II (67%). Layer II SST mRNA+ neuron density was reduced in schizophrenia (~29%). PV mRNA was reduced in layers III (18%) and IV (31%) with no significant diagnostic difference in PV mRNA measured by qPCR. FASR mRNA was increased in schizophrenia (34%). SST, but not PV, expression correlated negatively with FASR and TNFSF13 expressions and with IWMN density.
Our study demonstrates that SST interneurons are predominantly linked to the inhibitory interneuron pathology in the OFC in schizophrenia and that increased death receptor signaling mRNAs relate to prominent laminar deficits in SST mRNA in the OFC in schizophrenia. We suggest that SST interneurons may be more vulnerable to increased death receptor signaling than PV interneurons.
最近,我们提供了证据表明,精神分裂症患者眶额皮层(OFC)中的 GAD67 和 Dlx mRNA 减少。尚不清楚这些减少主要与生长抑素(SST)或小清蛋白(PV)mRNA 表达变化有关,以及这些减少是否与 SST mRNA+中间神经元密度降低有关。
确定精神分裂症患者 OFC 中的抑制性中间神经元缺陷是否主要针对 SST 或 PV mRNA,以及任何此类缺陷是否与编码细胞死亡信号分子的 mRNA 有关。
在对照和精神分裂症受试者(38/38)中测量抑制性中间神经元 mRNA(SST;PV:原位杂交,定量 PCR(qPCR))和死亡信号 mRNA [FAS 受体(FASR);TNFSF13:qPCR]。在直回的 II 层中量化 SST mRNA+中间神经元样细胞。灰质 SST 和 PV mRNA 与间质白质神经元(GAD65/67;NeuN)密度和死亡信号 mRNA 相关。
精神分裂症患者的 OFC 层 I-VI 中 SST mRNA 减少(原位和 qPCR 均如此),其中 II 层的缺陷最大(67%)。精神分裂症患者的 II 层 SST mRNA+神经元密度减少(约 29%)。PV mRNA 在 III 层(18%)和 IV 层(31%)减少,但 qPCR 测量的 PV mRNA 无明显诊断差异。FASR mRNA 在精神分裂症患者中增加(34%)。SST,但不是 PV,表达与 FASR 和 TNFSF13 表达以及 IWMN 密度呈负相关。
我们的研究表明,SST 中间神经元主要与精神分裂症患者 OFC 中的抑制性中间神经元病理有关,并且增加的死亡受体信号 mRNA 与精神分裂症患者 OFC 中 SST mRNA 的明显层缺陷有关。我们认为 SST 中间神经元可能比 PV 中间神经元更容易受到增加的死亡受体信号的影响。